loading
Connect Biopharma Holdings Ltd Adr stock is traded at $2.00, with a volume of 240.60K. It is down -0.99% in the last 24 hours and up +88.68% over the past month. Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
See More
Previous Close:
$2.02
Open:
$2.01
24h Volume:
240.60K
Relative Volume:
1.72
Market Cap:
$111.12M
Revenue:
-
Net Income/Loss:
$-21.38M
P/E Ratio:
-5.1282
EPS:
-0.39
Net Cash Flow:
$-25.19M
1W Performance:
-9.91%
1M Performance:
+88.68%
6M Performance:
+105.76%
1Y Performance:
+69.49%
1-Day Range:
Value
$1.83
$2.19
1-Week Range:
Value
$1.70
$2.28
52-Week Range:
Value
$0.51
$2.86

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Company Profile

Name
Name
Connect Biopharma Holdings Ltd Adr
Name
Phone
858-727-1040
Name
Address
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Name
Employee
62
Name
Twitter
Name
Next Earnings Date
2024-04-16
Name
Latest SEC Filings
Name
CNTB's Discussions on Twitter

Compare CNTB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CNTB
Connect Biopharma Holdings Ltd Adr
2.00 112.23M 0 -21.38M -25.19M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-12-25 Initiated H.C. Wainwright Buy
Mar-04-24 Initiated H.C. Wainwright Buy
Apr-13-21 Initiated Jefferies Buy
Apr-13-21 Initiated Piper Sandler Overweight
Apr-13-21 Initiated SVB Leerink Outperform

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Latest News

pulisher
Aug 01, 2025

Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq - MSN

Aug 01, 2025
pulisher
Jul 30, 2025

What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Jul 30, 2025
pulisher
Jul 27, 2025

Research Analysts Set Expectations for CNTB Q2 Earnings - MarketBeat

Jul 27, 2025
pulisher
Jul 25, 2025

Connect Biopharma (NASDAQ:CNTB) Upgraded at Northland Capmk - Defense World

Jul 25, 2025
pulisher
Jul 25, 2025

Q2 Earnings Estimate for CNTB Issued By Northland Capmk - Defense World

Jul 25, 2025
pulisher
Jul 22, 2025

Connect Biopharma stock rating reiterated as Outperform by Northland - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Connect Biopharma appoints Jim Schoeneck to board of directors By Investing.com - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 22, 2025

Connect Biopharma appoints James A. Schoeneck to board of directors By Investing.com - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 22, 2025

Northland starts Connect Biopharma at Outperform on chance to define new class - TipRanks

Jul 22, 2025
pulisher
Jul 21, 2025

Connect Biopharma stock rises after announcing plan to terminate ADR program - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma to terminate ADR program, list ordinary shares By Investing.com - Investing.com Canada

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma to terminate ADR program, list ordinary shares - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma to Terminate ADR Program and List Ordinary Shares on Nasdaq - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma Announces Plans to Terminate its American - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma Streamlines Trading: ADRs Convert to Direct Nasdaq Shares in Major US Market Push - Stock Titan

Jul 21, 2025
pulisher
Jul 18, 2025

Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire Inc.

Jul 18, 2025
pulisher
Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with minimum bid price rule - Investing.com India

Jul 17, 2025
pulisher
Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with minimum bid price rule By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with $1 minimum bid price - Investing.com

Jul 17, 2025
pulisher
Jul 09, 2025

Connect Biopharma’s partner submits new drug application in China - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

Connect Biopharma’s partner submits new drug application in China By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 08, 2025

Connect Biopharma (NASDAQ:CNTB) Trading Down 2.5% – Here’s What Happened - Defense World

Jul 08, 2025
pulisher
Jun 13, 2025

Connect Biopharma reports positive data for asthma treatment By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

Connect Biopharma reports positive data for asthma treatment - Investing.com

Jun 13, 2025
pulisher
May 13, 2025

Connect Biopharma begins Phase 2 asthma study - Investing.com

May 13, 2025
pulisher
Apr 04, 2025

Connect Biopharma stock hits 52-week low at $0.55 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Connect Biopharma stock hits 52-week low at $0.55 amid market challenges - Investing.com

Apr 04, 2025
pulisher
Apr 01, 2025

FDA greenlights Connect Biopharma’s asthma and COPD trials - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Connect Biopharma stock holds $8 target, Buy rating at H.C. Wainwright - Investing.com

Apr 01, 2025
pulisher
Mar 29, 2025

Connect Biopharma faces Nasdaq delisting over share price By Investing.com - Investing.com India

Mar 29, 2025
pulisher
Mar 28, 2025

Connect Biopharma faces Nasdaq delisting over share price - Investing.com

Mar 28, 2025
pulisher
Mar 27, 2025

Connect Biopharma stock hits 52-week low at $0.76 - Investing.com

Mar 27, 2025
pulisher
Feb 18, 2025

Connect Biopharma stock hits 52-week low at $0.91 amid market challenges - Investing.com India

Feb 18, 2025
pulisher
Jan 22, 2025

Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com

Jan 22, 2025
pulisher
Dec 18, 2024

Top 3 Aerospace and Defense Stocks Flying Under the Radar - The Globe and Mail

Dec 18, 2024
pulisher
Mar 03, 2024

CPIX Stock Quote Price and Forecast - CNN

Mar 03, 2024
pulisher
Nov 28, 2023

Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year? - Nasdaq

Nov 28, 2023
pulisher
Mar 20, 2023

Stocks Set to Open Lower as Investors Await Fed Meeting, Banking Sector Remains in Focus - Barchart.com

Mar 20, 2023
pulisher
May 12, 2022

What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth

May 12, 2022
pulisher
May 05, 2022

HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace

May 05, 2022
pulisher
Mar 31, 2022

Making it harder to "buy" China, Inc. - USC-China Institute

Mar 31, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Mar 19, 2021

CNTB News Today | Why did Connect Biopharma stock go down today? - MarketBeat

Mar 19, 2021
pulisher
Mar 19, 2021

Connect Biopharma (CNTB) Stock Price, News & Analysis - MarketBeat

Mar 19, 2021
pulisher
Nov 21, 2017

Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat

Nov 21, 2017
pulisher
Jan 02, 2017

52 Week HighUnited States Stocks - Investing.com

Jan 02, 2017

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):